Action for Pulmonary Fibrosis > News > Research > Norwich Medical School team recruits 300th IPF patient for drug trial

Norwich Medical School team recruits 300th IPF patient for drug trial

Congratulations to the Norwich Medical School team for recruiting the 300th patient to the EME-TIPAC trial on treating pulmonary fibrosis with co-trimoxazole (an antibiotic).

Norwich Clinical Trials Unit is coordinating the nationwide trial, which is taking place at 43 centres across the UK. The study aims to discover whether taking co-trimoxazole, alongside other treatments, improves life expectancy and reduces the chances of IPF patients being admitted to hospital.

If you want to know more about the research, contact your hospital consultant or Action for Pulmonary Fibrosis at info@actionpulmonaryfibrosis.org.

Sign up to receive our newsletter

Never miss our news—sign up to receive our quarterly newsletter and we'll keep you updated about any important announcements, new research and lots of fundraiser stories.